Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 7, 2019
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
Tue, August 6, 2019
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
[ Tue, Aug 06th 2019
] - WOPRAI
Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $136 on, Aug 6th, 2019
Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $143 to $136 on, Aug 6th, 2019.
Matthew has made no other calls on BLUE in the last 4 months.
There are 2 other peers that have a rating on BLUE. Out of the 2 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Matthew
- Jason McCarthy of "Maxim Group" Upgraded from Hold to Strong Buy and Held Target at $160 on, Tuesday, June 18th, 2019
- Matthew Luchini of "BMO Capital" Maintained at Buy with Decreased Target to $163 on, Monday, June 17th, 2019
